Abdul Wadood Siddiqui | RAMA UNIVERSITY (original) (raw)

Uploads

Papers by Abdul Wadood Siddiqui

Research paper thumbnail of Evaluation of acute and sub-chronic toxicity of Semelil (ANGIPARSTM), a new phytotherapeutic drug for wound healing in rodents

DARU Journal of Pharmaceutical Sciences, 2008

Abstract: Semelil (ANGIPARS TM), an herbal formulation containing Melilotus officinalis extract, ... more Abstract: Semelil (ANGIPARS TM), an herbal formulation containing Melilotus officinalis extract, is a novel compound being developed for treatment of chronic wounds, particularly diabetic foot ulcers. The purpose of this study was to investigate toxicological, pharmacological, and pathomorphological effects of IM and IP administration of Semelil in animals.

Research paper thumbnail of DESIGN OF NEW PEROXISOME PROLIFERATORS GAMMA ACTIVATED RECEPTOR AGONISTS (PPARγ) VIA QSAR BASED MODELING

Journal of Applied Pharmaceutical Sciences and Research, 2018

Introduction: The Peroxisome proliferators-activated receptors (PPARs) are one of the nuclear fat... more Introduction: The Peroxisome proliferators-activated receptors (PPARs) are one of the nuclear fatty acid receptors, which contain a type II zinc finger DNA binding pattern and a hydrophobic ligand binding pocket. These receptors are thought to play an essential role in metabolic diseases such as obesity, insulin resistance, and coronary artery disease. Therefore Peroxisome Proliferators-Activated Receptor (PPARγ) activators have drawn great recent attention in the clinical management of type 2 diabetes mellitus, prompting several attempts to discover and optimize new PPARγ activators. Objective: The aim of the study was to finding new selective human PPARγ (PPARγ) modulators that are able to improve glucose homeostasis with reduced side effects compared with TZDs and identify the specific molecular descriptor and structural constraint to improve the agonist activity of PPARγ analogs. Material and Method: Software's that was used for this study include S.P. Gupta QSAR software (QSAR analysis), Valstat (Comparative QSAR analysis and calculation of L-O-O, Q 2 , r 2 , Spress), BILIN (Comparative QSAR analysis and calculation of Q 2 , r, S, Spress, and F), etc., allowing directly performing statistical analysis. Then multiple linear regression based QSAR software (received from BITS-Pilani, India) generates QSAR equations. Result and Discussion: In this study, we explored the quantitative structure-activity relationship (QSAR) study of a series of meta-substituted Phenyl-propanoic acids as Peroxisome Proliferators Gamma activated receptor agonists (PPARγ). The activities of meta-substituted Phenyl-propanoic acids derivatives correlated with various physicochemical, electronic and steric parameters. Conclusion: The identified QSAR models highlighted the significance of molar refractivity and hydrophobicity to the biological activity.

Research paper thumbnail of Evaluation of acute and sub-chronic toxicity of Semelil (ANGIPARSTM), a new phytotherapeutic drug for wound healing in rodents

DARU Journal of Pharmaceutical Sciences, 2008

Abstract: Semelil (ANGIPARS TM), an herbal formulation containing Melilotus officinalis extract, ... more Abstract: Semelil (ANGIPARS TM), an herbal formulation containing Melilotus officinalis extract, is a novel compound being developed for treatment of chronic wounds, particularly diabetic foot ulcers. The purpose of this study was to investigate toxicological, pharmacological, and pathomorphological effects of IM and IP administration of Semelil in animals.

Research paper thumbnail of DESIGN OF NEW PEROXISOME PROLIFERATORS GAMMA ACTIVATED RECEPTOR AGONISTS (PPARγ) VIA QSAR BASED MODELING

Journal of Applied Pharmaceutical Sciences and Research, 2018

Introduction: The Peroxisome proliferators-activated receptors (PPARs) are one of the nuclear fat... more Introduction: The Peroxisome proliferators-activated receptors (PPARs) are one of the nuclear fatty acid receptors, which contain a type II zinc finger DNA binding pattern and a hydrophobic ligand binding pocket. These receptors are thought to play an essential role in metabolic diseases such as obesity, insulin resistance, and coronary artery disease. Therefore Peroxisome Proliferators-Activated Receptor (PPARγ) activators have drawn great recent attention in the clinical management of type 2 diabetes mellitus, prompting several attempts to discover and optimize new PPARγ activators. Objective: The aim of the study was to finding new selective human PPARγ (PPARγ) modulators that are able to improve glucose homeostasis with reduced side effects compared with TZDs and identify the specific molecular descriptor and structural constraint to improve the agonist activity of PPARγ analogs. Material and Method: Software's that was used for this study include S.P. Gupta QSAR software (QSAR analysis), Valstat (Comparative QSAR analysis and calculation of L-O-O, Q 2 , r 2 , Spress), BILIN (Comparative QSAR analysis and calculation of Q 2 , r, S, Spress, and F), etc., allowing directly performing statistical analysis. Then multiple linear regression based QSAR software (received from BITS-Pilani, India) generates QSAR equations. Result and Discussion: In this study, we explored the quantitative structure-activity relationship (QSAR) study of a series of meta-substituted Phenyl-propanoic acids as Peroxisome Proliferators Gamma activated receptor agonists (PPARγ). The activities of meta-substituted Phenyl-propanoic acids derivatives correlated with various physicochemical, electronic and steric parameters. Conclusion: The identified QSAR models highlighted the significance of molar refractivity and hydrophobicity to the biological activity.